Explore how Farxiga and Invokana are transforming diabetes management by effectively controlling blood sugar levels. These FDA-approved medications offer new hope for individuals with Type 2 diabetes to improve their health and reduce complications. Combining medication with lifestyle changes is essential for optimal results. Learn about the functioning, benefits, and side effects of these innovative treatments to understand their role in diabetes care.

How Farxiga and Invokana Support Better Blood Sugar Control

Diabetes and prediabetes are among the leading health issues worldwide. According to the American Diabetes Association, a 50-year-old diagnosed with diabetes experiences about six fewer years of life compared to non-diabetic individuals. Most cases involve Type 2 diabetes. Medical professionals emphasize that combining effective medication with lifestyle changes such as regular exercise, balanced diet, and weight control is vital for optimal health outcomes.

The Importance of Medications in Blood Glucose Regulation
Appropriate treatment options play a critical role in managing diabetes, making accessible drugs essential for effective care.

According to Lancelet Diabetes and Endocrinology, newer medicines help many individuals with Type 2 diabetes lead healthier, more manageable lives. Uncontrolled high blood sugar can cause serious issues like kidney disease, vision loss, infections, nerve damage, heart problems, and erectile dysfunction.

Key Therapeutics for Diabetes Control
In response to the rising prevalence of the condition, the FDA has approved advanced treatments such as Farxiga and Invokana to improve patient health outcomes.

Invokana (Canagliflozin)
Certified by the FDA in March 2013, Invokana belongs to the SGLT2 inhibitor class, working by preventing kidneys from reabsorbing glucose and promoting its excretion through urine. This oral drug is used alongside diet and physical activity to better manage advanced Type 2 diabetes. Clinical studies with over 10,000 participants showed consistent reductions in hemoglobin A1C and fasting glucose. Side effects may include nausea, vomiting, stomach upset, fatigue, and respiratory issues.

Farxiga (Dapagliflozin)
Approved by the FDA in January 2014, Farxiga helps control blood sugar levels in adults with Type 2 diabetes when used with diet and exercise. Results from 16 clinical trials with 9,400 patients confirmed its effectiveness. It can be used alone or with other medications. Common side effects are urinary tract infections, yeast infections, and increased urination.

Both Farxiga and Invokana mark significant advances in diabetes treatment. Your healthcare provider can advise if these options suit your specific health situation.